Skip to main content
. 2022 Jun 29;37(3):415–429. doi: 10.3803/EnM.2022.304

Fig. 2.

Fig. 2.

Extra-glycemic effects of anti-diabetic medications. GLP-1RA, glucagon-like peptide receptor agonist; DPP-4, dipeptidyl peptidase 4; SGLT2, sodium-glucose cotransporter 2; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; TZD, thiazolidinedione.